Rendering of Fujifilm Cellular Dynamics' forthcoming site in Madison, WI. (Credit: Fujifilm)
December 4, 2023 02:43 PM EST
Pharma
Manufacturing

Fu­ji­film makes $200M man­u­fac­tur­ing in­vest­ment while No­var­tis pours $80M+ in­to Chi­na fa­cil­i­ty

Katherine Lewin

News Reporter

Fu­ji­film Cor­po­ra­tion is in­vest­ing $200 mil­lion in­to two of its sub­sidiaries to ex­pand its cell ther­a­py con­tract de­vel­op­ment and man­u­fac­tur­ing,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times